CFTR and cystic fibrosis: Small molecule chaperones, cystic fibrossis transmembrane conductance regulator (CFTR) correctors, have been successfully applied to and approved for reverting folding defects of the CFTR-ΔF508 mutant in cystic fibrosis (35–37).